Example collocations logo

Treatments in sentence

516 examples of Treatments in a sentence

In particular, these regions should train and deploy a new cadre of community health workers, trained to recognize disease symptoms, provide surveillance, and administer diagnoses and appropriate treatments.
A catfight is now underway about which institution has been right over the past few years, the IMF with its tough treatments or the World Bank and its alternative cures.
The World Bank’s alternative treatments and Japan’s Asian IMF are, despite lip service, not drawing too many clients.
That finding immediately became a source of deep concern, because artemisinin is a critical ingredient in treatments for Plasmodium falciparum malaria, the deadliest form of the mosquito-borne parasite.
Specifically, there is a need for more high-quality data on the performance of programmatic interventions, and on the efficacy of current treatments.
In other words, you can have two years of gradual decline with some pain, or three years of nauseating treatments, “chemo brain,” loss of hair, and diminished dignity.
Medstory has a deep understanding of health care, including the relationships between diseases and treatments, drugs and symptoms, and side effects.
In addition, scientific research on this most accessible of human organs will continue to identify innovative treatments and modes of prevention, which may well become applicable to other cancers.
The local hospitals lack the equipment needed to perform many important procedures, like radiation treatments for cancer patients and heart surgery.
In recent decades, doctors have become much more comfortable giving physical treatments to remedy psychological and social problems.
A wide range of effective treatments are available that don’t cause weight gain, sexual dysfunction, diabetes, memory loss, or addiction.
If these new treatments aren’t used more frequently, this isn’t because they don’t work.
This is unacceptable, especially given the availability of treatments for these diseases.
Moreover, those who buy care – insurers and patients – are unlikely to have the information necessary to choose the safest and most effective treatments.
It will also depend on institutions’ ability to design rational health care, monitor delivery, and properly assess new treatments.
While the researchers who originally published those studies may have profited from increased funding and recognition, the patients who need new cancer treatments gained nothing.
Much of today’s bottled water, however, is not glacier or natural spring water but processed water, which is municipal water or, more often, directly extracted groundwater that has been subjected to reverse osmosis or other purification treatments.
In Liberia, 60% of markets are now closed; in Sierra Leone, only one-fifth of the 10,000 HIV patients who are on anti-retroviral treatments are still receiving them; and Guinea’s government is reporting a $220 million financing gap because of the crisis.
The history of the field is littered with definitions of entire disease categories that have been influenced by diagnostic fashions, politics, and the availability of treatments.
Most psychiatric treatments are effective across a wide range of diagnoses, whatever their origin.
But despite the paucity of success, the typical goal in cancer therapy remains similar to that of antimicrobial treatments – killing as many tumor cells as possible under the assumption that this will, at best, cure the disease and, at worst, keep the patient alive for as long as possible.
Finally, researchers should compare the long-term cost-effectiveness of different treatments in typical chronic-pain patients.
Such an approach would be more relevant and generalizable than industry-sponsored short-term studies that compare new treatments to placebos in a fastidiously chosen population that does not reflect real-world conditions.
A thorough and realistic understanding of the nature of chronic pain is crucial to devising effective treatments.
Moreover, we must invest in research and development of low-cost diabetes treatments and diagnostic tools that are suited for low-resource environments.
People understandably become disillusioned when their government or the business community doesn’t seem to value them, especially when such treatments stems from their gender, race, religion, sexual identity, or national origin.
The science case that probably played the most significant role in the campaign was a suit filed by the British Chiropractic Association against science writer Simon Singh for an article he published in The Guardian in 2008, in which he discussed “bogus treatments.”
Once it became clear that the epidemic would not be rapidly contained, several firms quickly arranged for clinical trials of potential treatments and vaccines, indicating that they already had the ability to produce plausible candidates.
It is not certain that the existence of such a fund prior to the recent Ebola outbreak would have led to the development of vaccines or treatments for the disease.
But pharmaceutical companies would have been considering such products – as well as other treatments to save lives or improve health anywhere in the world, regardless of people’s ability to pay.
BackNext